PI3 K/AKT/mTOR通路及其在乳腺癌干细胞中的作用
Kirti S Prabhu1, Shilpa Kuttikrishnan1, Zahwa Mariyam1
1Translational Research Institute, Academic Health System, Hamad Medical Corporation, PO Box 3050, Doha, 3050, Qatar.
Naunyn-Schmiedeberg's archives of pharmacology
|July 17, 2025
概括
针对癌症干细胞 (CSC) 中的PI3K/AKT/mTOR途径至关重要. 本综述强调了该途径在乳腺CSC中的作用及其控制瘤生长的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症干细胞 (CSCs) 驱动瘤的开始和扩散.
- 在各种癌症中,PI3K/AKT/mTOR通路经常受到失调.
- 这一途径与关键的CSC属性 (如茎状和迁移) 有关.
研究的目的:
- 审查PI3K/AKT/mTOR信号通路的作用,特别是在乳腺中枢细胞中.
- 探索乳房CSC中这种途径的治疗向策略.
主要方法:
- 对研究PI3K/AKT/mTOR途径在乳腺癌和骨髓癌中进行的研究的文献综述.
- 综合关于乳房CSC中途径功能的当前知识.
- 分析潜在的治疗应用.
主要成果:
- PI3K/AKT/mTOR途径是乳腺中枢细胞干,增殖,迁移,上皮-介质细胞过渡和自的组成部分.
- 这种途径的异常激活有助于乳房CSCs的攻击性表型.
- 针对这种途径显示出抑制乳腺CSC生长和扩散的前景.
结论:
- PI3K/AKT/mTOR通路是乳腺中枢细胞行为的关键调节者.
- 抑制这种途径代表了乳腺癌治疗的有前途的治疗策略.
- 对PI3K/AKT/mTOR抑制剂的进一步研究是有必要的,以便在乳腺中枢细胞中临床应用.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K


